What medicine is used for aplastic anemia?

Written by Li Fang Fang
Hematology
Updated on September 21, 2024
00:00
00:00

Aplastic anemia, whether acute or chronic, primarily uses immunosuppressive agents and hematopoietic stimulants for treatment. Cyclosporine is commonly used clinically among immunosuppressants, while the medicines stimulating bone marrow hematopoiesis mainly include androgens such as danazol and stanozolol. These medications all have associated adverse reactions: immunosuppressants can lead to hypertension, hyperglycemia, impaired liver and kidney function, and gum hypertrophy, while the main adverse reactions of hematopoietic androgens are liver damage. (Please use medications under the guidance of a doctor.)

Other Voices

doctor image
home-news-image
Written by Li Fang Fang
Hematology
48sec home-news-image

Can aplastic anemia be cured completely?

Aplastic anemia clinically is categorized into acute aplastic anemia and chronic aplastic anemia. Acute aplastic anemia appears suddenly and is severe, with a short survival period. Chronic aplastic anemia develops slowly, has a longer history, and is relatively milder in condition. Whether it is acute aplastic anemia or chronic aplastic anemia, curative treatment can only be achieved through allogeneic hematopoietic stem cell transplantation. Although allogeneic hematopoietic stem cell transplantation offers a potential cure for aplastic anemia, there is also a certain rate of failure. Additionally, post-transplant, there is a presence of immune rejection.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
41sec home-news-image

What medicine is used for aplastic anemia?

The main drugs used for aplastic anemia are immunosuppressants and cyclosporine. In addition to cyclosporine, low doses of hormones, androgens, and traditional Chinese medicine can also be used to stimulate bone marrow hematopoiesis. If the medication is effective, continue with oral administration; if ineffective, further consideration of bone marrow transplantation is needed. During the treatment process, it is necessary to regularly review the routine blood tests and, if necessary, provide support treatment with red blood cell and platelet transfusions.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
45sec home-news-image

What causes aplastic anemia?

Aplastic anemia's exact causes are still not completely clear. Clinically, it is believed that immune dysfunction is a significant factor associated with aplastic anemia. Most cases of aplastic anemia can achieve good therapeutic outcomes through immunosuppressive treatment, which indirectly supports this view. However, some scholars believe that in aplastic anemia, there are patients for whom immunosuppressive treatment is ineffective. This suggests that other factors might exist, such as congenital anomalies in hematopoietic stem and progenitor cells, or abnormalities in the hematopoietic microenvironment, which may also play a role in the development of aplastic anemia.

doctor image
home-news-image
Written by Peng Miao Yun
Internal Medicine
47sec home-news-image

The main diagnostic basis for aplastic anemia

Aplastic anemia is caused by a variety of reasons leading to bone marrow hematopoietic failure. So, what is the main diagnostic basis for diagnosing aplastic anemia? It is primarily the bone marrow examination, which shows decreased or severely decreased proliferation at least in one site, such as active proliferation, significant reduction in megakaryocytes, and an increase in non-hematopoietic cells in the bone marrow's granular components. Additionally, there can be a decrease in total blood cells, white cells, red cells, etc., and a reduction in the absolute value of reticulocytes.

doctor image
home-news-image
Written by Zhang Xiao Le
Hematology
1min 13sec home-news-image

Are the liver and kidney functions normal in patients with aplastic anemia?

Patients with aplastic anemia generally have normal liver and kidney functions. However, in certain special circumstances, abnormalities in liver and kidney functions may occur, including: Firstly, the routine treatment for aplastic anemia mainly includes the immunosuppressant cyclosporine and the hematopoietic stimulant androgens. The primary side effect of cyclosporine is renal toxicity. Therefore, during the use of cyclosporine, it is necessary to monitor the concentration of cyclosporine; excessive levels can lead to renal dysfunction. Androgens, including stanozolol and danazol, primarily cause hepatic toxicity; hence, it is necessary to monitor liver and kidney functions during treatment of aplastic anemia. The second factor that may cause liver and kidney function abnormalities is severe anemia. Long-term severe anemia can lead to tissue ischemia and hypoxia in the liver or kidneys, and if prolonged, it can cause abnormalities in liver and kidney functions. (Medication use should be carried out under the guidance of a physician.)